QQ客服 官方微博 反馈留言

	LRRK2 G2019S Mutation Inhibits Degradation of α-Synuclein in an In Vitro Model of Parkinson's Disease.
	Hu Dan; Niu Jian-Yi; Xiong Jing; Nie Shu-Ke; Zeng Fei; Zhang Zhao-Hui
刊名	Current medical science
	2018
卷号	Vol.38 No.6页码:1012-1017
关键词	Parkinson’s disease leucine-rich repeat kinase 2 lysosome α-synuclein
ISSN号	2523-899X
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5460549
专题	湖南大学
作者单位	1.Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, 430060, China. Department of Neurology, Yidu Central Hospital, Weifang Medical College, Weifang, 262500, China. Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, 430060, China. zhzhqing1990@16 2.com.
推荐引用方式 GB/T 7714	Hu Dan,Niu Jian-Yi,Xiong Jing,et al. LRRK2 G2019S Mutation Inhibits Degradation of α-Synuclein in an In Vitro Model of Parkinson's Disease.[J]. Current medical science,2018,Vol.38 No.6:1012-1017.
APA	Hu Dan,Niu Jian-Yi,Xiong Jing,Nie Shu-Ke,Zeng Fei,&Zhang Zhao-Hui.(2018).LRRK2 G2019S Mutation Inhibits Degradation of α-Synuclein in an In Vitro Model of Parkinson's Disease..Current medical science,Vol.38 No.6,1012-1017.
MLA	Hu Dan,et al."LRRK2 G2019S Mutation Inhibits Degradation of α-Synuclein in an In Vitro Model of Parkinson's Disease.".Current medical science Vol.38 No.6(2018):1012-1017.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。